Philips, HeartStart FR2+
• Trusted by those trained to save lives
• For professional and lay responder alike, HeartStart FR2+ was designed for fast, efficient operation
(1) SMART CPR. Patient specific treatment.
• The HeartStart SMART CPR evaluates key characteristics of the presenting ventricular fibrillation and determines the initial therapy: shock first, or CPR first quickly followed by a shock.
(2) Easy hand-off. Allows a continuity of patient care.
• Advanced life support (ALS) trained professionals can easily switch the HeartStart FR2+ to manual mode, giving them more decision-making control. An ECG display is also available for critical review.
(3) SMART Biphasic therapy. Safely delivers maximum shock strength.
• Philips SMART Biphasic therapy uses a unique combination of high current - to maximize effectiveness, and a lower energy dose - to minimize side effects that are harmful to a fragile heart.
(4) Built-in self test. Ready when needed. • Your HeartStart FR2+ goes through a 120-point test before it leaves the factory. On the job, it conducts self tests daily, not just weekly. It performs over 80 different tests, including pads integrity with visual & attention-getting audible alerts.
(5) Quick Shock feature. Reduce chest compressions.
• CPR is even more vital to survival than previously realized. Rapidly delivering a shock after chest compressions is critical. The HeartStart FR2+’s Quick Shock feature reduces the time between hands-off and shock delivery.
(6) Simple to use. Clear, calm voice commands.
• Operation of the HeartStart FR2+ is guided by clear, streamlined, confident, and concise, voice commands: ideal for responders who are trained, drilled, and ready to save a life.
Defibrillator Model: With ECG M3860A - With Text Only Display M3861A
How Supplied: Defibrillator, instructions for use, standard battery, defibrillator pads (2 pair), Quick Reference Guide.
Waveform: Truncated Exponential Biphasic. Waveform parameters adjusted as a function of each patient’s impedance
Therapy: Adult defibrillation peak current: 32A (150J nominal) into a 50 ohm load. Pediatric defibrillation (with optional Infant/Child SMART Pads Cartridge): 19A (50J nominal) into a 50 ohm load
Charge Time from Shock Advised : Typically less than 10 seconds
Charge Time in Manual Mode : Typically less than 5 seconds
Shock-to-Shock Cycle Time: Typically less than 15 seconds (including analysis time) in automated mode
Protocol: Text and voice prompts guide user through protocol. Follows pre-configured settings. Can be modified with the M3864A training and administration pack
Shock Delivery: Via defibrillator pads placed in anterior-anterior (lead II) position for adult defibrillation and anterior-posterior for infant/child defibrillation
Controls: On/Off, Shock, screen contrast/option buttons
Indicators: LCD screen, beeper, audio speakers, status indicator. Shock button connector socket LED
Advanced Mode: Configurable protocol
Height: 21.8 cm. (8.6 inches)
Width: 21.8 cm. (8.6 inches)
Depth: 6.6 cm. (2.6 inches)
Weight: With battery: 2.1 kg. (4.7 pounds) - Without battery: 1.8 kg (3.9 pounds)
ECG Display (M3860A):
Screen: High-resolution LCD with bright back-light
Screen Dimensions: 2.8 inches wide x 2.3 inches high (7.0 cm x 5.8 cm)
Display Range: Differential: ±2 mV full scale (nominal)
Sweep Speed: 23 mm/second (nominal)
Frequency Response: 1 Hz to 20 Hz (-3dB) (nominal)
Sensitivity: 1.16 cm/mV (nominal)
Heart Rate: 30 to 300 beats per minute updated each analysis period during monitoring
Monitored Lead: Anterior-anterior (lead II) placement with adult defibrillation pads or ECG Assessment Module (M3860A) only
Patient Analysis System:
Patient Analysis: Per protocol, evaluates patient ECG and signal quality to determine if rhythm is shockable, and evaluates connection impedance for proper defibrillation pad contact
Sensitivity/Specificity: Meets AAMI DF80 guidelines and AHA recommendations for adult defibrillation (Circulation 1997;95:1677-1682)
SMART CPR (configurable):
• Enables support of an automated or user-initiated CPR interval prior to defibrillation shockable rhythm. Once the decision is made, FR2+ provides the responder with the appropriate prompts
• SMART AUTO 1: advises CPR for patients with a presenting rhythm typical of very long-duration cardiac arrest
• SMART AUTO 2: advises CPR for an expanded group of patients inclusive of those in Auto 1, having a rhythm typical of long duration cardiac arrest
• USER: user-initiated CPR Pause interval. Supports a protocol under which the responder decides whether to perform CPR first. A Pause-for-CPR button is enabled, and can be pressed at the responder’s discretion
• The AUTO 1 and AUTO 2 settings automate the decision of whether to provide CPR first or deliver a shock first based on the amplitude and frequency of the presenting rhythm
Battery Type(M5070A): 9 Volt DC, 4.2 Ah, composed of disposable long-life lithium manganese dioxide primary cells
Capacity: Minimum 200 shocks or 4 hours of operating time (EN 60601-2-4:2003)
Install-By-Date: Battery is labeled with an install-by date of at least five years from date of manufacture
Standby Life: Four years typical when battery is installed by the install-by date. (Will power the AED in standby state within the specified standby Temperature range, assuming one battery insertion test and no defibrillation uses.)
Automated and User Activated Self-Tests:
Automatic Self-Tests: Tests internal circuitry, waveform delivery system, pads cartridge and battery capacity. Verifies calibration of key circuits monthly
Automatic Standby Temperature Monitoring: Instrument automatically monitors temperature and warns user if device is stored outside of standby temperature range
Battery Insertion Test: Upon battery insertion, extensive automatic self-tests and user-interactive test check device readiness.Verifies calibration of key circuits
Status Indication: Dynamic visual and audible indication of self-test results. Indicates device readiness
|Product Views (click images for larger view)|